|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
00098088-e196-4de8-af79-3ff8ad5950c2 |
| 005 |
20240705000000.0 |
| 008 |
921218s1993 nyua b 001 0 eng c |
| 010 |
|
|
|a 92048300
|
| 020 |
|
|
|a 0824788095 (alk. paper)
|
| 035 |
|
|
|a (OCoLC)27187090
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|
| 050 |
1 |
0 |
|a RC271.I47
|b T48 1993
|
| 060 |
|
0 |
|a QZ 267 T3972
|
| 082 |
0 |
0 |
|a 616.99/2061
|2 20
|
| 245 |
0 |
0 |
|a Therapeutic applications of interleukin-2 /
|c edited by Michael B. Atkins, James W. Mier.
|
| 260 |
|
|
|a New York :
|b M. Dekker,
|c ©1993.
|
| 300 |
|
|
|a xviii, 494 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Basic and clinical oncology ;
|v 2
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Interleukin-2
|x Therapeutic use.
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy
|
| 650 |
|
2 |
|a Interleukin-2
|x therapeutic use
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy
|
| 700 |
1 |
|
|a Atkins, Michael B.,
|d 1954-
|
| 700 |
1 |
|
|a Mier, James W.,
|d 1947-
|
| 740 |
0 |
|
|a Therapeutic applications of interleukin-two.
|
| 830 |
|
0 |
|a Basic and clinical oncology
|v 2.
|
| 999 |
1 |
0 |
|i 00098088-e196-4de8-af79-3ff8ad5950c2
|l 9956114770001701
|s US-MNU
|m therapeutic_applications_of_interleukin_2__________________________________1993_______mdekka___________________________________________________________________________p
|
| 999 |
1 |
1 |
|l 9956114770001701
|s ISIL:US-MNU
|i University of Minnesota
|t BKS
|a TBIOMGENS
|c QZ267 T3972 1993
|d NLM
|b 31951D00946856N
|x BOOK
|y 23491172140001701
|p LOANABLE
|